HomeTagsVersanis Bio

Versanis Bio

Healthcare

Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

News Desk - July 17, 2023

Eli Lilly and Company and Versanis Bio announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the...

Biotechnology

Versanis Presents Data Demonstrating Bimagrumab Treatment Leads to Substantial Fat Mass Loss Coupled with Lean Mass Gain in Diabetic

PR Newswire - June 14, 2022

Versanis Bio ("Versanis"), a clinical-stage company advancing novel therapeutics for cardiometabolic diseases, will share analysis of Phase 2 data from prior studies of lead...